Moors & Cabot, Inc. Trans Medics Group, Inc. Transaction History
Moors & Cabot, Inc.
- $2.17 Billion
- Q3 2025
A detailed history of Moors & Cabot, Inc. transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Moors & Cabot, Inc. holds 1,866 shares of TMDX stock, worth $214,608. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,866Holding current value
$214,608% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding TMDX
# of Institutions
440Shares Held
30.4MCall Options Held
1.03MPut Options Held
934K-
Vanguard Group Inc Valley Forge, PA3.61MShares$415 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$304 Million0.01% of portfolio
-
State Street Corp Boston, MA1.28MShares$147 Million0.01% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL1.07MShares$123 Million0.03% of portfolio
-
Macquarie Group LTD Australia, C3906KShares$104 Million0.12% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $3.66B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...